Ching-Sheng Hsu

发表

Characterization of esophageal pressure‐flow abnormalities in patients with non‐obstructive dysphagia and normal manometry findings

T. Omari, C. Yi, Chien-Lin Chen, 2013, Journal of gastroenterology and hepatology.

Integrative Functional Genomics of Hepatitis C Virus Infection Identifies Host Dependencies in Complete Viral Replication Cycle

Fang Zhang, Emmanuel Thomas, Qisheng Li, 2014, PLoS pathogens.

Clinical and psychological characteristics in gastroesophageal reflux disease patients overlapping with laryngopharyngeal reflux symptoms

C. Gyawali, M. Vaezi, W. Lei, 2019, Journal of gastroenterology and hepatology.

Predictive factors of silent reflux in subjects with erosive esophagitis.

F. Pace, Chia-Chi Wang, W. Lei, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence.

Ching-Sheng Hsu, 2013, JAMA.

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2008, Journal of gastroenterology and hepatology.

Metabolic profiles in patients with chronic hepatitis C: a case–control study

Ding‐Shinn Chen, Pei-Jer Chen, J. Kao, 2008, Hepatology international.

Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis.

T. Tseng, J. Kao, Chia-Chi Wang, 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia

J. Kao, Ching-Sheng Hsu, 2017, Expert review of gastroenterology & hepatology.

Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome

Chia-Chi Wang, W. Lei, C. Yi, 2015, European journal of gastroenterology & hepatology.

Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection

Ding‐Shinn Chen, Pei-Jer Chen, T. Tseng, 2010, Hepatology international.

Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten‐year observation

J. Kao, Tzy-Haw Wu, Ching-Sheng Hsu, 2010, Journal of gastroenterology and hepatology.

Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease

Ding‐Shinn Chen, J. Kao, Ching-Sheng Hsu, 2009, Hepatology.

Association of Rheumatoid Arthritis and Hepatitis B Infection

Ching-Sheng Hsu, Kuang-Yung Huang, H. Lin, 2016, Medicine.

Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study

Ching-Sheng Hsu, Cheng-Yi Chan, Sou-Yi Chang, 2021, Tzu chi medical journal.

Percutaneous endoscopic gastrostomy placement in Taiwan.

Ching-Sheng Hsu, Chao‐Chuan Wu, Tung-En Kuo, 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin.

Ding‐Shinn Chen, T. Tseng, J. Kao, 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma

Ding‐Shinn Chen, J. Kao, Ching-Sheng Hsu, 2015, Scientific Reports.

Management of non-alcoholic fatty liver disease in patients with sarcopenia

J. Kao, Ching-Sheng Hsu, 2021, Expert opinion on pharmacotherapy.

Outcomes of HCV treatment: Who does well and who does not?

J. Kao, Ching-Sheng Hsu, 2010, Journal of gastroenterology and hepatology.

Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy

Ding‐Shinn Chen, J. Kao, Ching-Sheng Hsu, 2016, Scientific Reports.

Il-21R Gene Polymorphisms and Serum Il-21 Levels Predict Virological Response to Interferon-Based Therapy in Asian Chronic Hepatitis C Patients

Ding‐Shinn Chen, Pei-Jer Chen, J. Kao, 2013, Antiviral therapy.

IL-21 R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients

Ding‐Shinn Chen, Pei-Jer Chen, J. Kao, 2013 .

Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients

Ding‐Shinn Chen, Pei-Jer Chen, J. Kao, 2013, Hepatology International.

HCV Core Gene Polymorphisms Correlate with Liver Fibrosis but Not Sustained Virological Response in Patients with Genotype 1 Infection

Ding‐Shinn Chen, Pei-Jer Chen, J. Kao, 2011, Antiviral therapy.

Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy

Ding‐Shinn Chen, Pei-Jer Chen, J. Kao, 2009, Antiviral therapy.

Early Viral Kinetics during Treatment of Chronic Hepatitis C Virus Infection with Pegylated Interferon Alpha plus Ribavirin in Taiwan

Ding‐Shinn Chen, Pei-Jer Chen, J. Kao, 2007, Intervirology.

Association of Insulin Resistance with Alanine Aminotransferase Activity in Patients with Nonalcoholic Fatty Liver Disease

J. Kao, Chia-Chi Wang, Ching-Sheng Hsu, 2008 .

Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link?

J. Kao, Ching-Sheng Hsu, 2008, Hepatology.

Role of viral factors in modifying weight-related effects on disease progression of chronic hepatitis C patients.

J. Kao, Ching-Sheng Hsu, 2010, Gastroenterology.

Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non‐alcoholic fatty liver disease

T. Tseng, J. Kao, Chia-Chi Wang, 2009, Journal of gastroenterology and hepatology.

Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling

Ding‐Shinn Chen, J. Kao, Ching-Sheng Hsu, 2011, Proceedings of the National Academy of Sciences.

Boceprevir for chronic HCV genotype 1 infection.

J. Kao, Ching-Sheng Hsu, A. Limaye, 2011, The New England journal of medicine.

Esomeprazole for asthma.

J. Kao, Ching-Sheng Hsu, 2009, The New England journal of medicine.

Therapeutic efficacy of nivolumab plus sorafenib therapy in patients with unresectable hepatocellular carcinoma.

Ching-Sheng Hsu, Sou-Yi Chang, Yen-Chih Chen, 2022, International immunopharmacology.

Alpha-fetoprotein in chronic hepatitis C.

J. Kao, Ching-Sheng Hsu, 2011, Journal of the Formosan Medical Association = Taiwan yi zhi.

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir

T. Tseng, J. Kao, T. Su, 2013, Journal of gastroenterology and hepatology.

Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2010, Journal of gastroenterology and hepatology.

Association of Lipid Profiles With Hepatitis C Viral Load in Chronic Hepatitis C Patients With Genotype 1 or 2 Infection

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2009, The American Journal of Gastroenterology.

Use of statins and gallstone risk.

J. Kao, Ching-Sheng Hsu, 2010, JAMA.

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

Sheng-Nan Lu, Ching-Sheng Hsu, Ming‐Lung Yu, 2020, Hepatology International.

Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2011, Hepatology international.

Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics

F. Pace, W. Lei, J. Hung, 2017, Digestive Diseases and Sciences.

Effect of Host and Viral Factors on Hepatitis B E Antigen-Positive Chronic Hepatitis B Patients Receiving Pegylated Interferon-α-2A Therapy

Ding‐Shinn Chen, T. Tseng, J. Kao, 2011, Antiviral therapy.

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B

Ding‐Shinn Chen, T. Tseng, J. Kao, 2010, Antiviral therapy.

Fluvastatin helps interferon‐based therapy in chronic hepatitis C: Fact or fiction?

J. Kao, Ching-Sheng Hsu, 2013, Journal of gastroenterology and hepatology.

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

Ding‐Shinn Chen, T. Tseng, J. Kao, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV/HCV Coinfection in Taiwan.

J. Kao, Ching-Sheng Hsu, 2016, AIDS reviews.

Sleep Disturbance and Its Association with Gastrointestinal Symptoms/Diseases and Psychological Comorbidity

W. Lei, J. Hung, C. Yi, 2018, Digestion.

Sofosbuvir for previously untreated chronic hepatitis C infection.

Ching-Sheng Hsu, 2013, The New England journal of medicine.

Utility of balloon expulsion test in patients with constipation: Preliminary results in a single center

W. Lei, J. Hung, C. Yi, 2016 .

Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C.

J. Kao, Ching-Sheng Hsu, 2009, The New England journal of medicine.

Genomic variation-guided management in chronic hepatitis C

J. Kao, Ching-Sheng Hsu, 2012, Expert review of gastroenterology & hepatology.

Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan

Ching-Sheng Hsu, Kuang-Yung Huang, Y. Chao, 2018, Hepatology International.

Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.

Ching-Sheng Hsu, Yen-Chih Chen, Y. Chao, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Hepatitis C virus genotypes 1-3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes.

Qisheng Li, T. Liang, Ding‐Shinn Chen, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sarcopenia and chronic liver diseases

J. Kao, Ching-Sheng Hsu, 2018, Expert review of gastroenterology & hepatology.

W. Lei, J. Hung, C. Yi, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: A 5-year population-based cohort study.

W. Lei, J. Hung, C. Yi, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

The utility of HCV core antigen for evaluation of viremia at 48 weeks posttreatment with direct‐acting antivirals

Ching-Sheng Hsu, Yen-Chun Chen, Chih-Wei Tseng, 2022, Advances in Digestive Medicine.

Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.

F. Pace, M. Vaezi, W. Lei, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

T. Tseng, J. Kao, Chia-Chi Wang, 2012, The Kaohsiung journal of medical sciences.

Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection

Ding‐Shinn Chen, T. Tseng, J. Kao, 2015, Hepatology International.

Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients

J. Kao, Ching-Sheng Hsu, Y. Chao, 2013, PloS one.

Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection

Qisheng Li, T. Liang, Ching-Sheng Hsu, 2015, Journal of Virology.

Hepatitis C infection and metabolic syndrome.

J. Kao, Ching-Sheng Hsu, 2010, Journal of the Formosan Medical Association = Taiwan yi zhi.

News and Perspectives Hepatitis C Infection and Metabolic Syndrome

J. Kao, Ching-Sheng Hsu, 2010 .

High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan.

J. Kao, Ching-Sheng Hsu, 2012, Journal of the Formosan Medical Association = Taiwan yi zhi.

Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-Analysis

Ching-Sheng Hsu, Yen-Chun Chen, Chih-Wei Tseng, 2023, Cancers.

Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway

Ding‐Shinn Chen, J. Kao, Ching-Sheng Hsu, 2016, Proceedings of the National Academy of Sciences.

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

Ding‐Shinn Chen, T. Tseng, J. Kao, 2011, Proceedings of the National Academy of Sciences.

Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis

T. Tseng, Chia-Chi Wang, Ching-Sheng Hsu, 2012, Journal of gastroenterology and hepatology.

Clinical characteristics and psychosocial impact of different reflux time in gastroesophageal reflux disease patients.

Chia-Chi Wang, C. Yi, T. Liu, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Hepatitis C virus and lipid profiles: more questions than answers?

J. Kao, Ching-Sheng Hsu, 2011, Hepatology international.

Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment

M. Yuen, Chien-Hung Chen, Ching-Sheng Hsu, 2020, Clinical and molecular hepatology.

Rescue for interferon failures in HCV genotype 1/HBV dually infection.

Ching-Sheng Hsu, Chao‐Chuan Wu, 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

Interferon‐based therapy reduces risk of stroke in chronic hepatitis C patients: a population‐based cohort study in Taiwan

J. Kao, Ching-Sheng Hsu, Y. Chao, 2013, Alimentary pharmacology & therapeutics.

Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2010, Journal of gastroenterology and hepatology.

Role of viral factors in modifying weight-related effects on disease progression of chronic hepatitis C patients.

J. Kao, Ching-Sheng Hsu, 2010, Gastroenterology.

Management of hepatitis C patients with decompensated liver disease

J. Kao, Ching-Sheng Hsu, 2016, Expert review of gastroenterology & hepatology.